Insulin attenuates endotoxin-induced acute lung injury in conscious rats

被引:66
作者
Chen, HI
Yeh, DY
Liou, HL
Kao, SJ
机构
[1] Shin Kong Wu Ho Su Mem Hosp, Dept Chest Med, Taipei 111, Taiwan
[2] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan
[3] Taipei Vet Gen Hosp, Dept Nursing, Taipei, Taiwan
[4] Taipei Med Univ, Coll Med, Sch Resp Therapy, Taipei, Taiwan
[5] Fu Jen Catholic Univ, Taipei, Taiwan
关键词
acute lung injury; lipopolysaccharide; glucose; nitric oxide; free radical; hyperglycemia;
D O I
10.1097/01.CCM.0000201902.37115.22
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Objectives. To investigate the effects of insulin on the acute lung injury induced by lipopolysaccharide using a conscious rat model. Design: Prospective, randomized, controlled animal study. Setting: University research laboratory. Subjects. A total of 190 adult male Sprague-Dawley rats weighing 250-300 g. Interventions: Endotoxemia was induced by intravenous infusion of lipopolysaccharide. Lipopolysaccharide at various doses (0, 1, 5, 10, 20, and 30 mg/kg, n = 10 for each dose) was administered intravenously in 20 mins. Insulin infusion at doses of 0.5, 1, and 5 mu U/kg/min was given 5 mins before lipopolysaccharide administration. Plasma glucose was clamped at 90-110 mg/dL by infusion of 10-80% glucose solution. Insulin and glucose infusion (0.01 mL/min) was started 5 mins before lipopolysaccharide and continued for 120 mins. The rats received a total of 60,120, and 600 mu U/kg insulin as well as 0.12, 0.36, and 0.96 g of glucose in respective groups. The animals were then observed for 4 hrs. Measurements and Main Results. The extent of acute lung injury was evaluated by lung weight/body weight ratio, lung weight gain, protein concentration in bronchoalveolar lavage, and exhaled nitric oxide. We also measured plasma nitrate/nitrite and methyl guanidine. In addition, histopathologic changes of the lung were examined. Lipopolysaccharide caused systemic hypotension and severe acute lung injury with increases in plasma nitrate/nitrite and methyl guanidine. Pretreatment with insulin infusion at doses of 0.5, 1, and 5 mu U/kg/min mitigated or prevented systemic hypotension and the development of acute lung injury, depending on the dose. Insulin also attenuated the lipopolysaccharide-induced increases in nitrate/nitrite and methyl guanidine. Conclusions: Insulin is effective in reducing or preventing the lipopolysaccharide-induced increases in plasma nitrate/nitrite and methyl guanidine and the occurrence of acute lung injury.
引用
收藏
页码:758 / 764
页数:7
相关论文
共 42 条
[1]   Role of NF kappa B in the mortality of sepsis [J].
Bohrer, H ;
Qiu, F ;
Zimmerman, T ;
Zhang, YM ;
Jllmer, T ;
Mannel, D ;
Bottiger, BW ;
Stern, DM ;
Waldherr, R ;
Saeger, HD ;
Ziegler, R ;
Bierhaus, A ;
Martin, E ;
Nawroth, PP .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (05) :972-985
[2]   Sepsis: A new hypothesis for pathogenesis of the disease process [J].
Bone, RC ;
Grodzin, CJ ;
Balk, RA .
CHEST, 1997, 112 (01) :235-243
[3]   Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response [J].
Brix-Christensen, V ;
Andersen, SK ;
Andersen, R ;
Mengel, A ;
Dyhr, T ;
Andersen, NT ;
Larsson, A ;
Schmitz, O ;
Orskov, H ;
Tonnesen, E .
ANESTHESIOLOGY, 2004, 100 (04) :861-870
[4]   Comparison of enterovirus 71 and coxsackievirus A16 clinical illnesses during the Taiwan enterovirus epidemic, 1998 [J].
Chang, LY ;
Lin, TY ;
Huang, YC ;
Tsao, KC ;
Shih, SR ;
Kuo, ML ;
Ning, HC ;
Chung, PW ;
Kang, CM .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1999, 18 (12) :1092-1096
[5]   Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease [J].
Chang, LY ;
Lin, TY ;
Hsu, KH ;
Huang, YC ;
Lin, KL ;
Hsueh, C ;
Shih, SR ;
Ning, HC ;
Hwang, MS ;
Wang, HS ;
Lee, CY .
LANCET, 1999, 354 (9191) :1682-1686
[6]   Acute respiratory distress syndrome [J].
Chen, HI ;
Kao, SJ ;
Wang, D ;
Lee, RP ;
Su, CF .
JOURNAL OF BIOMEDICAL SCIENCE, 2003, 10 (06) :588-592
[7]   Nitric oxide in systemic and pulmonary hypertension [J].
Chen, HI ;
Hu, CT ;
Wu, CY ;
Wang, D .
JOURNAL OF BIOMEDICAL SCIENCE, 1997, 4 (05) :244-248
[8]  
Chen HI, 1997, AM J PHYSIOL, V273, P1816
[9]   RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].
FISHER, CJ ;
DHAINAUT, JFA ;
OPAL, SM ;
PRIBBLE, JP ;
BALK, RA ;
SLOTMAN, GJ ;
IBERTI, TJ ;
RACKOW, EC ;
SHAPIRO, MJ ;
GREENMAN, RL ;
REINES, HD ;
SHELLY, MP ;
THOMPSON, BW ;
LABRECQUE, JF ;
CATALANO, MA ;
KNAUS, WA ;
SADOFF, JC ;
ASTIZ, M ;
CARPATI, C ;
BONE, RC ;
FREIDMAN, B ;
MURE, AJ ;
BRATHWAITE, C ;
SHAPIRO, E ;
MELHORN, L ;
TAYLOR, R ;
KEEGAN, M ;
OBRIEN, J ;
SCHEIN, R ;
PENA, M ;
WASSERLOUF, M ;
OROPELLO, J ;
BENJAMIN, E ;
DELGUIDICE, R ;
EMMANUEL, G ;
LIE, T ;
ANDERSON, L ;
MARSHALL, J ;
DEMAJO, W ;
ROTSTEIN, O ;
FOSTER, D ;
ABRAHAM, E ;
MIDDLETON, H ;
PERRY, C ;
LEVY, H ;
FRY, DE ;
SIMPSON, SQ ;
CROWELL, RE ;
NEIDHART, M ;
STEVENS, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (23) :1836-1843
[10]   Meta-analysis of controlled trials of anticoagulant therapies in patients with sepsis [J].
Freeman, BD ;
Zehnbauer, BA ;
Buchman, TG .
SHOCK, 2003, 20 (01) :5-9